NASDAQ : CTSO
Cytosorbents Corporation — Financial statements
Healthcare · Medical Devices · United States
Last price 4.54 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 14.31M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Cytosorbents Corporation (CTSO) reported revenue of 37.22M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 37.22M | 37.06M | 35.59M | 31.08M | 34.69M | 43.17M |
| Revenue | 37.22M | 37.06M | 35.59M | 31.08M | 34.69M | 43.17M |
| Cost of Revenue | 10.57M | 10.57M | 10.71M | 9.13M | 13.96M | 11.05M |
| Gross Profit | 26.65M | 26.49M | 24.89M | 21.95M | 20.73M | 32.12M |
| Selling, General & Admin | 33.78M | 35.65M | 33.73M | 38.31M | 36.50M | 38.48M |
| Research & Development | 4.64M | 5.08M | 7.61M | 15.59M | 15.12M | 16.38M |
| Operating Expenses | 38.42M | 40.73M | 41.34M | 53.90M | 51.62M | 54.86M |
| Operating Income | -11.77M | -14.24M | -16.45M | -31.95M | -30.89M | -22.74M |
| Interest Expense | -3.12M | -2.61M | -1.40M | -157.89K | ||
| Interest & Investment Income | 132.60K | 28.01K | ||||
| Currency Exchange Gain (Loss) | -2.01M | 9.32M | -4.22M | 1.95M | -2.45M | -2.58M |
| Other Non Operating Income (Expenses) | 96.75K | -67.30K | ||||
| EBT Excluding Unusual Items | -16.90M | -7.53M | -22.08M | -30.06M | -33.27M | -25.29M |
| Merger & Restructuring Charges | -820.00K | -510.00K | ||||
| Asset Writedown | -897.00K | -559.00K | -334.00K | -636.00K | ||
| Pretax Income | -18.61M | -8.60M | -22.41M | -30.06M | -33.91M | -25.29M |
| Income Tax Expense | -401.00K | -401.00K | -1.69M | -813.74K | -1.09M | -736.00K |
| Net Income | -18.21M | -8.20M | -20.72M | -29.25M | -32.81M | -24.56M |
| Net Income to Common | -18.21M | -8.20M | -20.72M | -29.25M | -32.81M | -24.56M |
| Shares Outstanding (Basic) | 3.14M | 3.11M | 2.72M | 2.23M | 2.18M | 2.17M |
| Shares Outstanding (Diluted) | 3.14M | 3.11M | 2.72M | 2.23M | 2.18M | 2.17M |
| EPS (Basic) | -5.80 | -2.63 | -7.61 | -13.10 | -15.06 | -11.33 |
| EPS (Diluted) | -5.82 | -2.63 | -7.61 | -13.10 | -15.06 | -11.33 |
| Free Cash Flow | -9.30M | -12.54M | -14.71M | -22.19M | -34.32M | -17.65M |
| Free Cash Flow Per Share | -2.96 | -4.03 | -5.41 | -9.94 | -15.75 | -8.14 |
| Gross Margin | 71.61% | 71.47% | 69.92% | 70.62% | 59.77% | 74.41% |
| Operating Margin | -31.63% | -38.42% | -46.22% | -102.78% | -89.04% | -52.69% |
| Profit Margin | -48.94% | -22.12% | -58.21% | -94.09% | -94.59% | -56.89% |
| Free Cash Flow Margin | -24.98% | -33.84% | -41.33% | -71.39% | -98.94% | -40.88% |
| EBITDA | -10.35M | -12.74M | -14.88M | -30.49M | -30.00M | -22.01M |
| EBITDA Margin | -27.81% | -34.38% | -41.81% | -98.08% | -86.49% | -51.00% |
| D&A For EBITDA | 1.42M | 1.50M | 1.57M | 1.46M | 882.62K | 731.58K |
| EBIT | -11.77M | -14.24M | -16.45M | -31.95M | -30.89M | -22.74M |
| EBIT Margin | -31.63% | -38.42% | -46.22% | -102.78% | -89.04% | -52.69% |
| Revenue as Reported | 34.69M | 43.17M | ||||
| Advertising Expenses | 300.00K | 300.00K | 582.00K | 615.00K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 4.41M | 6.25M | 3.28M | 14.13M | 22.14M | 52.14M |
| Cash & Short-Term Investments | 4.41M | 6.25M | 3.28M | 14.13M | 22.14M | 52.14M |
| Receivables | 6.79M | 7.55M | 7.32M | 6.06M | 5.66M | 4.52M |
| Inventory | 3.69M | 5.28M | 2.73M | 3.38M | 3.46M | 4.77M |
| Prepaid Expenses | 852.00K | 1.55M | 3.27M | 1.83M | 2.49M | 2.87M |
| Restricted Cash | 5.00M | |||||
| Total Current Assets | 15.74M | 20.63M | 21.60M | 25.40M | 33.76M | 64.30M |
| Property, Plant & Equipment | 17.78M | 18.75M | 20.51M | 22.12M | 23.35M | 18.57M |
| Other Intangible Assets | 2.86M | 3.23M | 3.72M | 3.91M | 4.39M | 4.70M |
| Other Long-Term Assets | 1.57M | 1.57M | 1.53M | 1.54M | 1.73M | 1.94M |
| Total Assets | 37.96M | 44.18M | 47.37M | 52.96M | 63.23M | 89.52M |
| Accounts Payable | 2.00M | 2.87M | 3.34M | 3.80M | 1.66M | 2.81M |
| Accrued Expenses | 5.06M | 5.06M | 4.71M | 4.99M | 6.43M | 8.37M |
| Current Portion of Long-Term Debt | 14.15M | 2.50M | ||||
| Current Portion of Leases | 589.00K | 541.00K | 453.00K | 373.64K | 108.94K | 570.57K |
| Current Unearned Revenue | 1.14M | 182.00K | 596.00K | 1.38M | 1.52M | 1.95M |
| Other Current Liabilities | 1.08M | 1.05M | 722.00K | 991.54K | ||
| Total Current Liabilities | 24.02M | 9.71M | 9.82M | 14.04M | 9.71M | 13.69M |
| Long-Term Debt | 3.09M | 16.67M | 14.00M | 2.54M | 5.00M | |
| Long-Term Leases | 11.60M | 11.90M | 12.44M | 12.90M | 13.14M | 13.25M |
| Total Liabilities | 38.71M | 38.28M | 36.27M | 29.48M | 27.86M | 26.94M |
| Common Stock | 63.00K | 63.00K | 55.00K | 54.24K | 43.63K | 43.48K |
| Additional Paid-In Capital | 321.94M | 321.02M | 310.81M | 306.19M | 287.00M | 283.19M |
| Retained Earnings | -321.75M | -312.21M | -304.01M | -283.29M | -254.00M | -221.19M |
| Comprehensive Income & Other | -996.00K | -2.98M | 4.25M | 529.32K | 2.33M | 525.59K |
| Shareholders' Equity | -751.00K | 5.90M | 11.11M | 23.48M | 35.37M | 62.58M |
| Total Liabilities & Equity | 37.96M | 44.18M | 47.37M | 52.96M | 63.23M | 89.52M |
| Total Debt | 29.43M | 29.11M | 26.89M | 18.31M | 18.25M | 13.82M |
| Net Cash (Debt) | -25.01M | -22.86M | -23.61M | -4.18M | 3.89M | 38.32M |
| Net Cash Per Share | -7.97 | -7.35 | -8.68 | -1.87 | 1.79 | 17.67 |
| Filing Date Shares Outstanding | 3.14M | 3.13M | 3.12M | 2.71M | 2.18M | 2.18M |
| Total Common Shares Outstanding | 3.14M | 3.14M | 2.74M | 2.71M | 2.18M | 2.17M |
| Working Capital | -8.29M | 10.93M | 11.78M | 11.36M | 24.05M | 50.61M |
| Book Value Per Share | -0.24 | 1.88 | 4.05 | 8.66 | 16.21 | 28.79 |
| Tangible Book Value | -3.62M | 2.68M | 7.39M | 19.57M | 30.98M | 57.88M |
| Tangible Book Value Per Share | -1.15 | 0.85 | 2.69 | 7.22 | 14.20 | 26.62 |
| Machinery | 6.60M | 6.66M | 6.95M | 6.87M | 6.44M | 7.29M |
| Leasehold Improvements | 6.30M | 6.31M | 6.28M | 6.22M | 6.20M | 2.62M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -18.21M | -8.20M | -20.72M | -29.25M | -32.81M | -24.56M |
| Depreciation & Amortization | 1.54M | 1.63M | 1.74M | 2.02M | 1.13M | 1.13M |
| Other Amortization | 1.01M | 820.00K | 381.00K | |||
| Loss (Gain) From Sale of Assets | 132.30K | |||||
| Asset Writedown & Restructuring Costs | 1.00M | 663.00K | 334.00K | 655.68K | 635.61K | |
| Stock-Based Compensation | 2.29M | 2.77M | 3.76M | 4.16M | 3.80M | 6.20M |
| Provision & Write-off of Bad Debts | 271.00K | 40.00K | 115.00K | 14.43K | -8.35K | -512.00 |
| Other Operating Activities | 2.01M | -9.07M | 4.34M | -1.91M | 2.45M | 2.58M |
| Change in Accounts Receivable | 543.00K | 423.00K | -1.72M | -245.62K | -1.29M | 420.58K |
| Change in Inventory | -103.00K | -2.54M | 500.00K | 183.27K | 945.35K | -2.35M |
| Change in Accounts Payable | -33.00K | -706.00K | -1.81M | 1.61M | -3.25M | 2.43M |
| Change in Other Net Operating Assets | 542.00K | 1.79M | -1.35M | 1.10M | 30.49K | 145.06K |
| Operating Cash Flow | -9.15M | -12.38M | -14.43M | -21.66M | -28.23M | -14.01M |
| Capital Expenditures | -150.00K | -164.00K | -284.00K | -538.12K | -6.09M | -3.64M |
| Sale of Property, Plant & Equipment | 161.00K | 76.00K | ||||
| Sale (Purchase) of Intangibles | -286.00K | -327.00K | -385.00K | -398.12K | -368.21K | -640.01K |
| Investing Cash Flow | -275.00K | -415.00K | -669.00K | -936.24K | -6.46M | -4.28M |
| Long-Term Debt Issued | 2.48M | 15.00M | 5.00M | |||
| Long-Term Debt Repaid | -5.00M | |||||
| Net Debt Issued (Repaid) | 2.48M | 2.48M | 10.00M | 5.00M | ||
| Issuance of Common Stock | 6.83M | 179.00K | 14.47M | 805.20K | ||
| Other Financing Activities | -848.00K | -40.36K | -90.00K | |||
| Financing Cash Flow | 2.48M | 9.31M | 9.33M | 14.47M | 4.96M | 715.20K |
| Foreign Exchange Rate Adjustments | 1.15M | 1.49M | -85.00K | -99.77K | -262.92K | -24.77K |
| Net Cash Flow | -5.79M | -1.99M | -5.85M | -8.22M | -29.99M | -17.60M |
| Free Cash Flow | -9.30M | -12.54M | -14.71M | -22.19M | -34.32M | -17.65M |
| Free Cash Flow Margin | -24.98% | -33.84% | -41.33% | -71.39% | -98.94% | -40.88% |
| Free Cash Flow Per Share | -2.96 | -4.03 | -5.41 | -9.94 | -15.75 | -8.14 |
| Levered Free Cash Flow | -3.51M | -2.07M | -14.79M | -12.92M | -23.80M | -8.88M |
| Unlevered Free Cash Flow | -2.57M | -1.26M | -14.29M | -12.82M | -23.80M | -8.88M |
| Cash Interest Paid | 2.28M | 2.08M | 1.29M | 376.67K | ||
| Change in Working Capital | 949.00K | -1.03M | -4.38M | 2.65M | -3.56M | 641.90K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 14.40M | 40.14M | 49.76M | 57.95M | 67.64M | 182.16M |
| Enterprise Value | 39.41M | 59.74M | 70.88M | 67.64M | 58.47M | 134.77M |
| Last Close Price | 4.54 | 12.78 | 18.20 | 22.20 | 31.00 | 83.80 |
| PS Ratio | 0.38 | 1.08 | 1.40 | 1.86 | 1.95 | 4.22 |
| PB Ratio | 6.80 | 4.48 | 2.47 | 1.91 | 2.91 | |
| P/TBV Ratio | 15.00 | 6.74 | 2.96 | 2.18 | 3.15 | |
| EV/Sales Ratio | 1.06 | 1.61 | 1.99 | 2.18 | 1.69 | 3.12 |
| Debt / Equity Ratio | -39.18 | 4.93 | 2.42 | 0.78 | 0.52 | 0.22 |
| Net Debt / Equity Ratio | -33.31 | 3.87 | 2.13 | 0.18 | -0.11 | -0.61 |
| Net Debt / EBITDA Ratio | -2.42 | -1.79 | -1.59 | -0.14 | 0.13 | 1.74 |
| Net Debt / FCF Ratio | -2.69 | -1.82 | -1.60 | -0.19 | 0.11 | 2.17 |
| Asset Turnover | 0.87 | 0.81 | 0.71 | 0.54 | 0.45 | 0.48 |
| Inventory Turnover | 2.86 | 2.64 | 3.51 | 2.67 | 3.39 | 2.97 |
| Quick Ratio | 0.47 | 1.42 | 1.08 | 1.44 | 2.86 | 4.14 |
| Current Ratio | 0.66 | 2.12 | 2.20 | 1.81 | 3.48 | 4.70 |
| Return on Equity (ROE) | -336.21% | -96.39% | -119.80% | -99.38% | -67.00% | -34.64% |
| Return on Assets (ROA) | -17.12% | -19.44% | -20.50% | -34.37% | -25.27% | -15.84% |
| Return on Capital Employed (ROCE) | -84.50% | -41.30% | -43.80% | -82.10% | -57.70% | -30.00% |
| Earnings Yield | -127.40% | -20.42% | -41.64% | -50.47% | -48.51% | -13.48% |
| FCF Yield | -64.99% | -31.24% | -29.57% | -38.29% | -50.74% | -9.69% |
| Buyback Yield / Dilution | -8.00% | -14.32% | -21.90% | -2.49% | -0.49% | -11.70% |